Contact Meds TB-500 with editorial questions about the research.

What this channel is for

Use this form for editorial matters about the TB-500 research digest: a citation that looks wrong, a study we should consider, a place where the fragment-versus-full-length distinction could be clearer, or general feedback on the summaries. We read every message and we correct errors when they are pointed out.

This is an editorial contact channel and nothing more. We cannot answer medical questions, we do not provide health, dosing, or treatment guidance, and we have no clinician on the other end of this form to do so ^[5]. We do not sell, supply, source, or broker any substance, and we cannot help anyone obtain TB-500 — questions of that kind fall outside what this site does and outside the lawful framework summarized on the TB-500 legal status and FDA 503A category page ^[17].

What we can't do here

We can't tell you whether TB-500 is appropriate for any individual, because that is a clinical judgment and this is an editorial site ^[5]. We can't provide a protocol, a dose, or a route, because no controlled human dosing for the fragment exists and we do not give administration instructions ^[5]. And we can't point you to a vendor, pharmacy, clinic, or telehealth provider — naming one is outside both this site's purpose and the guardrails we hold to. What we can do is keep the research summaries accurate and well cited, and fix them when you catch something.